SPERA PHARMA INC. is a Japan-based pharmaceutical contract development and manufacturing company pioneering advanced analytical technologies such as MicroED (Microcrystal Electron Diffraction), alongside drug formulation, process development, and comprehensive analysis services. With a mission to accelerate drug discovery, the company supports clients from early research to clinical stages. SPERA PHARMA leverages cutting-edge methods including flow chemistry, solid form science, and nano-formulation to optimize drug candidates at the molecular level. Through innovation, quality, and a strong commitment to social responsibility, SPERA PHARMA contributes to the advancement of global healthcare.